Production (Stage)
Eastwood Bio-Medical Canada Inc.
EBM.V
TSX
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 17.81% | 17.32% | -23.72% | -35.07% | -146.62% |
| Total Depreciation and Amortization | 14.05% | -1.25% | -1.87% | -1.73% | -2.80% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 230.00% | 381.25% | 21.88% | 14.29% | 0.00% |
| Change in Net Operating Assets | -30.28% | -25.86% | 48.82% | 81.38% | 324.86% |
| Cash from Operations | -28.57% | 12.70% | 85.65% | 128.68% | -166.67% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -6.61% | -16.20% | 7.02% | -39.17% | -18.86% |
| Total Debt Repaid | 27.27% | 14.40% | -59.87% | -128.25% | 7.96% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 507.69% | -5.88% | -117.82% | -194.49% | -81.43% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 116.28% | 8.75% | 65.56% | -564.00% | -253.57% |